Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
Phase 1
Completed
- Conditions
- First Posted Date
- 2010-05-27
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01131689
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT01130753
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Study of Pazopanib With CAPEOX in AGC Patients
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 66
- Registration Number
- NCT01130805
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2010-05-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 176
- Registration Number
- NCT01130766
- Locations
- 🇰🇷
Samsung Medical Center, Seoul,, Korea, Republic of
The Continuation of Erlotinib
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2010-05-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 23
- Registration Number
- NCT01130779
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-05-19
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 222
- Registration Number
- NCT01125995
- Locations
- 🇰🇷
Asan Medican Center, Seoul, Korea, Republic of
🇰🇷Keunchil Park, Seoul, Korea, Republic of
Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-05-19
- Last Posted Date
- 2021-03-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT01126008
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-05-19
- Last Posted Date
- 2011-12-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 78
- Registration Number
- NCT01126060
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Effect of Bevacizumab on the Trabeculectomy
- First Posted Date
- 2010-05-13
- Last Posted Date
- 2010-05-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01122966
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2013-06-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT01106066
- Locations
- 🇰🇷
Samsung Cancer Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath